The pharmacy industry is at a pivotal moment. Rising costs, the affordability of specialty drugs, and middlemen who do not always have their clients’ best interest in mind have created a complex problem. Now is the time to streamline the process and provide the groups that are funding the cost of drugs with a long overdue lead role in the negotiating process. Read more about the state of the industry in this Pharmacy Times article by Thatcher Sloan, Vice President, Practice Leader, RxBenefits.
